Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
9.12
+0.14 (1.56%)
At close: Mar 9, 2026, 4:00 PM EDT
10.75
+1.63 (17.87%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Zevra Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 513 | 504 | 445 | 272 | 158 | 308 | |
| Market Cap Growth | 22.86% | 13.31% | 63.82% | 71.57% | -48.52% | 536.60% | |
| Enterprise Value | 386 | 368 | 416 | 233 | 97 | 178 | |
| Last Close Price | 9.12 | 8.96 | 8.34 | 6.55 | 4.59 | 8.71 | |
| PE Ratio | 6.76 | 6.06 | - | - | - | - | |
| Forward PE | 17.35 | 19.15 | - | - | - | - | |
| PS Ratio | 4.82 | 4.74 | 18.85 | 9.90 | 15.59 | 10.74 | |
| PB Ratio | 3.35 | 3.26 | 11.22 | 4.39 | 2.11 | 2.42 | |
| P/TBV Ratio | 3.58 | 3.51 | - | - | 2.11 | 2.42 | |
| P/FCF Ratio | - | - | - | - | - | 29.76 | |
| P/OCF Ratio | - | - | - | - | - | 29.47 | |
| EV/Sales Ratio | 3.62 | 3.45 | 17.61 | 8.49 | 9.52 | 6.21 | |
| EV/EBITDA Ratio | - | - | - | - | - | 22.27 | |
| EV/EBIT Ratio | - | - | - | - | - | 23.01 | |
| EV/FCF Ratio | - | - | - | - | - | 17.20 | |
| Debt / Equity Ratio | 0.41 | 0.41 | 1.52 | 0.71 | 0.19 | 0.01 | |
| Debt / EBITDA Ratio | 88.48 | 88.48 | - | - | - | 0.18 | |
| Debt / FCF Ratio | - | - | - | - | - | 0.16 | |
| Net Debt / Equity Ratio | -0.83 | -0.83 | -0.23 | -0.39 | -0.91 | -0.87 | |
| Net Debt / EBITDA Ratio | 713.99 | 713.99 | 0.11 | 0.49 | 2.87 | -13.87 | |
| Net Debt / FCF Ratio | 52.53 | 52.53 | 0.13 | 0.71 | 3.65 | -10.71 | |
| Asset Turnover | 0.46 | 0.46 | 0.14 | 0.19 | 0.08 | 0.40 | |
| Inventory Turnover | 8.89 | 8.89 | - | - | - | - | |
| Quick Ratio | 5.46 | 5.46 | 2.35 | 1.16 | 7.58 | 26.92 | |
| Current Ratio | 5.68 | 5.68 | 2.53 | 1.18 | 7.72 | 27.20 | |
| Return on Equity (ROE) | 85.66% | 85.66% | -207.84% | -67.23% | -26.48% | -28.18% | |
| Return on Assets (ROA) | -1.14% | -1.14% | -31.03% | -21.55% | -12.54% | 6.70% | |
| Return on Invested Capital (ROIC) | -35.00% | -14.18% | -254.55% | -223.98% | -218.60% | 94.82% | |
| Return on Capital Employed (ROCE) | -1.70% | -1.70% | -60.40% | -50.30% | -24.10% | 6.00% | |
| Earnings Yield | 16.21% | 16.50% | -23.70% | -16.95% | -16.90% | -2.78% | |
| FCF Yield | -0.47% | -0.48% | -15.65% | -12.45% | -11.88% | 3.36% | |
| Buyback Yield / Dilution | -23.81% | -23.81% | -30.46% | -2.79% | -15.87% | -647.72% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.